(4S,8R)-20,25-bis(6-acetyl-1-hydroxy-2-oxopyridine-3-carbonyl)-N-[2-(2-aminoethoxy)ethyl]-13,32-dihydroxy-2,10,12,15,30,33-hexaoxo-6-oxa-3,9,13,16,20,25,29,32-octazatetracyclo[29.2.2.211,14.04,8]heptatriaconta-1(34),11(37),14(36),31(35)-tetraene-21-carboxamide

C49H58N12O19 — CID 134313644

IUPAC(4S,8R)-20,25-bis(6-acetyl-1-hydroxy-2-oxopyridine-3-carbonyl)-N-[2-(2-aminoethoxy)ethyl]-13,32-dihydroxy-2,10,12,15,30,33-hexaoxo-6-oxa-3,9,13,16,20,25,29,32-octazatetracyclo[29.2.2.211,14.04,8]heptatriaconta-1(34),11(37),14(36),31(35)-tetraene-21-carboxamide
SMILESCC(=O)c1ccc(C(=O)N2CCCNC(=O)c3ccc(c(=O)n3O)C(=O)N[C@@H]3COC[C@@H]3NC(=O)c3ccc(n(O)c3=O)C(=O)NCCCN(C(=O)c3ccc(C(C)=O)n(O)c3=O)C(C(=O)NCCOCCN)CCC2)c(=O)n1O
InChIInChI=1S/C49H58N12O19/c1-26(62)34-11-9-30(48(73)58(34)75)44(69)56-19-3-6-36(41(66)53-18-23-79-22-15-50)57(45(70)31-10-12-35(27(2)63)59(76)49(31)74)21-5-17-52-43(68)38-14-8-29(47(72)61(38)78)40(65)55-33-25-80-24-32(33)54-39(64)28-7-13-37(60(77)46(28)71)42(67)51-16-4-20-56/h7-14,32-33,36,75-78H,3-6,15-25,50H2,1-2H3,(H,51,67)(H,52,68)(H,53,66)(H,54,64)(H,55,65)/t32-,33+,36?/m1/s1
InChIKeyVOFNAVXZSCEQMJ-BBZLWSGTSA-N
MW1119.07 g/mol
LogP-3.61
Rot. Bonds10

About (4S,8R)-20,25-bis(6-acetyl-1-hydroxy-2-oxopyridine-3-carbonyl)-N-[2-(2-aminoethoxy)ethyl]-13,32-dihydroxy-2,10,12,15,30,33-hexaoxo-6-oxa-3,9,13,16,20,25,29,32-octazatetracyclo[29.2.2.211,14.04,8]heptatriaconta-1(34),11(37),14(36),31(35)-tetraene-21-carboxamide

(4S,8R)-20,25-bis(6-acetyl-1-hydroxy-2-oxopyridine-3-carbonyl)-N-[2-(2-aminoethoxy)ethyl]-13,32-dihydroxy-2,10,12,15,30,33-hexaoxo-6-oxa-3,9,13,16,20,25,29,32-octazatetracyclo[29.2.2.211,14.04,8]heptatriaconta-1(34),11(37),14(36),31(35)-tetraene-21-carboxamide (PubChem CID 134313644) has the molecular formula C49H58N12O19 and a molecular weight of 1119.07 g/mol. Its IUPAC name is (4S,8R)-20,25-bis(6-acetyl-1-hydroxy-2-oxopyridine-3-carbonyl)-N-[2-(2-aminoethoxy)ethyl]-13,32-dihydroxy-2,10,12,15,30,33-hexaoxo-6-oxa-3,9,13,16,20,25,29,32-octazatetracyclo[29.2.2.211,14.04,8]heptatriaconta-1(34),11(37),14(36),31(35)-tetraene-21-carboxamide.

Molecular Properties

Compound Name(4S,8R)-20,25-bis(6-acetyl-1-hydroxy-2-oxopyridine-3-carbonyl)-N-[2-(2-aminoethoxy)ethyl]-13,32-dihydroxy-2,10,12,15,30,33-hexaoxo-6-oxa-3,9,13,16,20,25,29,32-octazatetracyclo[29.2.2.211,14.04,8]heptatriaconta-1(34),11(37),14(36),31(35)-tetraene-21-carboxamide
PubChem CID134313644
Molecular FormulaC49H58N12O19
Molecular Weight1119.07 g/mol
Exact Mass1118.39
IUPAC Name(4S,8R)-20,25-bis(6-acetyl-1-hydroxy-2-oxopyridine-3-carbonyl)-N-[2-(2-aminoethoxy)ethyl]-13,32-dihydroxy-2,10,12,15,30,33-hexaoxo-6-oxa-3,9,13,16,20,25,29,32-octazatetracyclo[29.2.2.211,14.04,8]heptatriaconta-1(34),11(37),14(36),31(35)-tetraene-21-carboxamide
SMILESCC(=O)c1ccc(C(=O)N2CCCNC(=O)c3ccc(c(=O)n3O)C(=O)N[C@@H]3COC[C@@H]3NC(=O)c3ccc(n(O)c3=O)C(=O)NCCCN(C(=O)c3ccc(C(C)=O)n(O)c3=O)C(C(=O)NCCOCCN)CCC2)c(=O)n1O
InChIInChI=1S/C49H58N12O19/c1-26(62)34-11-9-30(48(73)58(34)75)44(69)56-19-3-6-36(41(66)53-18-23-79-22-15-50)57(45(70)31-10-12-35(27(2)63)59(76)49(31)74)21-5-17-52-43(68)38-14-8-29(47(72)61(38)78)40(65)55-33-25-80-24-32(33)54-39(64)28-7-13-37(60(77)46(28)71)42(67)51-16-4-20-56/h7-14,32-33,36,75-78H,3-6,15-25,50H2,1-2H3,(H,51,67)(H,52,68)(H,53,66)(H,54,64)(H,55,65)/t32-,33+,36?/m1/s1
InChIKeyVOFNAVXZSCEQMJ-BBZLWSGTSA-N
XLogP-3.61
TPSA433.66 Ų
H-Bond Donors10
H-Bond Acceptors24
Rotatable Bonds10
Heavy Atoms80
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001119.07
LogP ≤ 5-3.61
H-Bond Donors ≤ 510
H-Bond Acceptors ≤ 1024

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'N-hydroxyl_pyridine', 'substructure': 'N/A'}

Analyze (4S,8R)-20,25-bis(6-acetyl-1-hydroxy-2-oxopyridine-3-carbonyl)-N-[2-(2-aminoethoxy)ethyl]-13,32-dihydroxy-2,10,12,15,30,33-hexaoxo-6-oxa-3,9,13,16,20,25,29,32-octazatetracyclo[29.2.2.211,14.04,8]heptatriaconta-1(34),11(37),14(36),31(35)-tetraene-21-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (4S,8R)-20,25-bis(6-acetyl-1-hydroxy-2-oxopyridine-3-carbonyl)-N-[2-(2-aminoethoxy)ethyl]-13,32-dihydroxy-2,10,12,15,30,33-hexaoxo-6-oxa-3,9,13,16,20,25,29,32-octazatetracyclo[29.2.2.211,14.04,8]heptatriaconta-1(34),11(37),14(36),31(35)-tetraene-21-carboxamide?
The IUPAC name of (4S,8R)-20,25-bis(6-acetyl-1-hydroxy-2-oxopyridine-3-carbonyl)-N-[2-(2-aminoethoxy)ethyl]-13,32-dihydroxy-2,10,12,15,30,33-hexaoxo-6-oxa-3,9,13,16,20,25,29,32-octazatetracyclo[29.2.2.211,14.04,8]heptatriaconta-1(34),11(37),14(36),31(35)-tetraene-21-carboxamide (CID 134313644) is (4S,8R)-20,25-bis(6-acetyl-1-hydroxy-2-oxopyridine-3-carbonyl)-N-[2-(2-aminoethoxy)ethyl]-13,32-dihydroxy-2,10,12,15,30,33-hexaoxo-6-oxa-3,9,13,16,20,25,29,32-octazatetracyclo[29.2.2.211,14.04,8]heptatriaconta-1(34),11(37),14(36),31(35)-tetraene-21-carboxamide.
What is the SMILES notation for (4S,8R)-20,25-bis(6-acetyl-1-hydroxy-2-oxopyridine-3-carbonyl)-N-[2-(2-aminoethoxy)ethyl]-13,32-dihydroxy-2,10,12,15,30,33-hexaoxo-6-oxa-3,9,13,16,20,25,29,32-octazatetracyclo[29.2.2.211,14.04,8]heptatriaconta-1(34),11(37),14(36),31(35)-tetraene-21-carboxamide?
The canonical SMILES for (4S,8R)-20,25-bis(6-acetyl-1-hydroxy-2-oxopyridine-3-carbonyl)-N-[2-(2-aminoethoxy)ethyl]-13,32-dihydroxy-2,10,12,15,30,33-hexaoxo-6-oxa-3,9,13,16,20,25,29,32-octazatetracyclo[29.2.2.211,14.04,8]heptatriaconta-1(34),11(37),14(36),31(35)-tetraene-21-carboxamide is CC(=O)c1ccc(C(=O)N2CCCNC(=O)c3ccc(c(=O)n3O)C(=O)N[C@@H]3COC[C@@H]3NC(=O)c3ccc(n(O)c3=O)C(=O)NCCCN(C(=O)c3ccc(C(C)=O)n(O)c3=O)C(C(=O)NCCOCCN)CCC2)c(=O)n1O.
What is the InChIKey of (4S,8R)-20,25-bis(6-acetyl-1-hydroxy-2-oxopyridine-3-carbonyl)-N-[2-(2-aminoethoxy)ethyl]-13,32-dihydroxy-2,10,12,15,30,33-hexaoxo-6-oxa-3,9,13,16,20,25,29,32-octazatetracyclo[29.2.2.211,14.04,8]heptatriaconta-1(34),11(37),14(36),31(35)-tetraene-21-carboxamide?
The InChIKey is VOFNAVXZSCEQMJ-BBZLWSGTSA-N. The full InChI is InChI=1S/C49H58N12O19/c1-26(62)34-11-9-30(48(73)58(34)75)44(69)56-19-3-6-36(41(66)53-18-23-79-22-15-50)57(45(70)31-10-12-35(27(2)63)59(76)49(31)74)21-5-17-52-43(68)38-14-8-29(47(72)61(38)78)40(65)55-33-25-80-24-32(33)54-39(64)28-7-13-37(60(77)46(28)71)42(67)51-16-4-20-56/h7-14,32-33,36,75-78H,3-6,15-25,50H2,1-2H3,(H,51,67)(H,52,68)(H,53,66)(H,54,64)(H,55,65)/t32-,33+,36?/m1/s1.
What are the key properties of (4S,8R)-20,25-bis(6-acetyl-1-hydroxy-2-oxopyridine-3-carbonyl)-N-[2-(2-aminoethoxy)ethyl]-13,32-dihydroxy-2,10,12,15,30,33-hexaoxo-6-oxa-3,9,13,16,20,25,29,32-octazatetracyclo[29.2.2.211,14.04,8]heptatriaconta-1(34),11(37),14(36),31(35)-tetraene-21-carboxamide?
(4S,8R)-20,25-bis(6-acetyl-1-hydroxy-2-oxopyridine-3-carbonyl)-N-[2-(2-aminoethoxy)ethyl]-13,32-dihydroxy-2,10,12,15,30,33-hexaoxo-6-oxa-3,9,13,16,20,25,29,32-octazatetracyclo[29.2.2.211,14.04,8]heptatriaconta-1(34),11(37),14(36),31(35)-tetraene-21-carboxamide has a molecular weight of 1119.07 g/mol, XLogP of -3.61, 10 rotatable bonds, 10 hydrogen bond donors, and 24 hydrogen bond acceptors.
Where does this data come from?
All data for (4S,8R)-20,25-bis(6-acetyl-1-hydroxy-2-oxopyridine-3-carbonyl)-N-[2-(2-aminoethoxy)ethyl]-13,32-dihydroxy-2,10,12,15,30,33-hexaoxo-6-oxa-3,9,13,16,20,25,29,32-octazatetracyclo[29.2.2.211,14.04,8]heptatriaconta-1(34),11(37),14(36),31(35)-tetraene-21-carboxamide is sourced from PubChem (CID 134313644), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).